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| INTRODUCTION
Patients with neurological disease may show various urological symptoms, depending on the type of disease and the neurological location of the lesion. 1, 2 Both storage and voiding problems can considerably reduce patients quality of life. 3 An impaired neurological control of the external sphincter may be the cause of stress urinary incontinence (SUI), defined as urinary incontinence that occurs on exertion, effort, sneezing, or coughing. 4 This bothersome condition affects many neuro-urological (NU) patients, typically those with a meningomyelocele or a conus-cauda equina lesion. 1 Owing to the fact that SUI in NU patients often occurs together with other urological dysfunction such as detrusor overactivity and reduced bladder compliance, 1,3 treatment of SUI in NU patients requires a specific approach. Moreover, NU patients may perceive bother from urinary incontinence differently compared to non-NU patients due to altered sensation and impaired mobility. Therefore, the outcome parameters and the definitions of success or cure used to report on outcome of surgical interventions for SUI in NU patients require specific attention.
To identify the most appropriate therapy, studies on the outcomes of the different therapies used to treat SUI in NU patients should ideally be reported in a standardized way. We performed a systematic review to describe all urinary parameters and definitions of success or cure used to report on outcome of surgical interventions for SUI in NU patients.
| MATERIALS AND METHODS

| Study registration
The study protocol was registered and published on PROSPERO (CRD42016033303) (http://www.crd.york.ac. uk/PROSPERO). This systematic review was performed and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 5 and Cochrane Handbook for Systematic Reviews of Interventions. 6 
| Literature search
The Medline, Embase, Cochrane controlled trials databases, and clinicaltrial.gov were systematically searched for all relevant publications until February 2017. The search strategy is available in Supplementary Material S1. Duplicates were removed. No date restrictions were applied. Non-English texts were excluded. Additionally, reference lists of relevant reviews were hand-searched for missed relevant articles.
| Study selection
Our aim was to include all publications of original studies that used a predefined urinary outcome parameter or a definition of success or cure to report on outcome of surgical interventions for SUI in adult NU patients. Conference abstracts, reviews, and case series with <10 NU patients were excluded. Reviews served only to check the references for eligible extra articles. Studies with both adult NU and non-NU patients or with both children and adult NU patients were included only if adult NU patients were separately reported on or if >90% of the study population were adult NU patients.
Endnote (EndNote X7, Thomson Reuters, 1500 Spring Garden Street, Fourth Floor, Philadelphia, PA 19130) was used to store identified abstracts and to sort the abstracts for inclusion and exclusion. Each title and abstract was reviewed for eligibility by two out of four reviewing authors (BB, JG, JS, SR) independently. Articles of which the abstract met the eligibility criteria were reviewed in full text. Full text selection was performed by two authors independently (JG, SR) using a standardized screening form. Discrepancy between the two authors was resolved by discussion or by consulting a third reviewer (BB). We reported on the literature search and study selection in a PRISMA flow diagram. 5 
| Outcomes
All urinary outcome parameters and definitions of cure or success used to report on outcome of surgical interventions for SUI in adult NU patients were summarized. Outcome parameters containing information from questionnaires and patient interviews were considered subjective outcome parameters. Outcome parameters were considered objective when derived from bladder diaries, pad tests, cough stresstests, or urodynamic investigations.
| Data extraction and risk of bias assessment
Data on general study characteristics were retrieved by the first author and checked by JG. Two authors (SR and JG) independently extracted predefined data from the included publications using a standardized data extraction form. A risk of bias analysis for included non-randomized comparative studies was performed by using the Cochrane Risk of bias Assessment Tool 7 in combination with an assessment of the main confounders following the recommendations of the Cochrane handbook for non-randomized comparative studies. 6 A list of the main confounders was developed and a priori agreed on with clinical content experts (EAU Neuro-Urology guidelines panel). Identified confounders were age, gender, mixed versus stress incontinence, underlying NU pathology, perineal sensation, previous treatments for SUI, and previous pelvic surgeries. Confounders were determined for the studies during data extraction. The confounding bias was classified as "high" if the confounder was not considered or described, was imbalanced between the groups or was unadjusted during analysis. The risk of bias in non-comparative studies was determined by assessing the attrition bias (incomplete outcome data), the reporting bias (selective outcome reporting), and availability of an a priori protocol. External validity of these studies was reported by assessing whether participants were selected consecutively. This is a pragmatic approach based on methodological literature. 8, 9 In addition, the main confounders were assessed for these studies. The risk of bias figure was computed in Review Manager (RevMan) version 5.3 (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).
| Subgroup analyses
Subgroup analyses were intended to be performed if there would be sufficient data. Predefined subgroups were men versus women, SUI versus mixed UI, underlying NU pathology, and no versus one/more former surgeries with potential effect on continence. 
| RESULTS
| Search results
| Characteristics of included studies
The included studies were published between 1995 and 2017 and report the results of various SUI surgeries. Table 1 shows the descriptives of the included studies. Most studies had a retrospective single-arm study design. With one exception, all studies were single-center studies. Twelve studies reported on NU patients only. A total of 452 NU patients were included in the studies. Most studies included mixed patient populations regarding underlying NU pathology, detrusor overactivity, mixed urinary incontinence and pure SUI, and patients with and without previous SUI, and other pelvic surgeries. Table 2 shows the outcome parameters used per study. In total, 16 different outcome parameters were used in the 17 included studies. Furthermore categorization of the outcomes differed (eg, patient-reported leakage/continence). Eleven studies had applied two or more outcome parameters. Six of the 17 studies reported on both an objective and a subjective outcome parameter. 
| Results on outcome parameters
| Subjective outcome parameters
Patient-reported pad use (number of pads/24 h or yes/no daily pad use reported during an interview) was the most utilized outcome parameter; used in eleven studies. Three studies applied standardized questionnaires. In seven studies patients reported on their urinary leakage status in a post-intervention interview. Two studies reported on patient satisfaction. Table 3 provides an overview of the different definitions for cure or continence used. Fifteen of 17 studies reported on such a definition. In these 15 studies, nine different definitions were used. Only two of five studies that reported on cure and used an objective and a subjective outcome parameter, used a combination of both outcomes to define cure.
| Results on definition of success or cure
| Subgroup analyses
It was not contributive or possible to perform subgroup analyses. First, the number of included studies was small; second, because most studies identified included mixed populations (gender, underlying NU pathology, SUI, and mixed UI, former surgeries with potential effect on continence); and finally, subanalyses and information on predefined groups was often missing (Table 1 ).
| Risk of bias assessment
Most of the included studies were assessed as having high or unclear risk of bias ( Figure 2) . In most retrospective studies, it was unclear if an a priori protocol was available and if there was selective outcome reporting. In one third of these studies, it was unclear if there were incomplete outcome data. Most studies included study participants consecutively. The two comparative studies had a high risk of bias for most assessed factors of the Cochrane Risk of bias Assessment Tool and the confounding factors. 
| DISCUSSION
| Principal findings
In this systematic review, we have presented all parameters and definitions of cure to report on the outcome of surgical interventions for SUI in adult NU patients. Sixteen different outcome parameters and nine different definitions of cure or continence were used. Most outcomes and definitions of cure were based on non-standardized patient self-assessments (of pad use per day or leakage/continence). A minority of studies made use of objective outcome parameters or validated questionnaires. To the best of our knowledge, this is the first systematic review on this topic in this specific patient group. It is evident that there is a considerable heterogeneity in the urinary outcome parameters and definitions of cure used to report on outcome of surgical interventions for SUI in adult NU patients.
| Findings in the context of the existing evidence
The heterogeneity of outcome reporting makes it more difficult to interpret and compare different studies and therapies. The Core Outcome Measures in Effectiveness Trials (COMET) initiative supports the development of standardized sets of outcomes in all fields of health research. 27 In the field of urology such core outcome sets are available for prostate cancer and male sexual dysfunction, but not for UI. The International Continence Society (ICS) and the International Consultation on Incontinence (ICI) recommend using both objective and subjective outcome parameters in UI research. 28, 29 Despite this, these organizations do not provide a definition of cure or make recommendations for the specific outcome parameters to be used. Specifically, in the field of NU patients undergoing SUI surgery there is no consensus on outcome parameters. The ICS does not provide a recommendation on this topic for research in NU patients. The ICI recommends using changes in detrusor leak point pressure for research purposes in NU patients if appropriate. 28 Nevertheless, this parameter was not used in any of the included studies in our systematic review. The EAU guidelines mention prevention of deterioration of the upper urinary tract and optimization of the quality of life as the most important urological treatment goals for NU patients. 30 Therefore, we would expect urodynamic investigations and quality of life measures to be used more often in this patient group. NU patients may have altered sensation and impaired mobility and consequently perceive (UI) complaints different than to non-NU patients. Thus, measuring patients' perception of UI complaints and their healthrelated quality of life (rather than quantifying symptoms) is important, especially in this patient group. Phé et al 31 32 found that urodynamic investigations were performed in 12 of 54 studies (22.2%) and in 37 of 92 studies (40.2%), respectively. Only two of the 17 (11.8%) studies in our review applied questionnaires on the impact of UI and only one study used quality-of-life assessments. The questionnaires administered were the UDI-6, IIQ-7, visual analog scale for continence, and ICIQ male short form. These are validated questionnaires, but not specifically for NU patients. Although validated (disease-specific) quality of life questionnaires such as the (SF-)Qualiveen 33, 34 have been introduced in the recent past, they have not always been available. In the review by Phé et al 31 Despite the ICS and ICI recommendations, in only six of 17 (35.3%) included studies in this systematic review both a subjective and an objective outcome parameter was used and only two of these studies used a combination of these parameters to define cure. Compared to the reviews of Phé et al 31 Pad use reported by the patient during an interview was the most used outcome parameter in the studies included in our systematic review. Phé et al 31 reported on this outcome for some studies, but not structurally for all and Castillo et al. 32 did not mention this outcome parameter in their review. In one included study 17 of our review this outcome parameter was chosen because it would reflect the quality of life, referring to a publication by Stoffel et al 35 that found a correlation between patient-reported pad use and the impact of UI on quality of life. In other publications the reason for choosing this outcome parameter is not clear, but might be the ease of collecting this information (especially for retrospective series) for both patient and researcher; in addition it does not interfere in a patient's "normal daily voiding routine" (as a bladder diary might do). It is questionable if patient-reported pad use during an interview reflects the quantity of urine lost 36 specifically for NU patients with altered sensation in whom the use of incontinence pads is often discouraged to prevent skin problems. Furthermore, it is unknown if patient-reported pad use is comparable to bladder diary reported pad use. As using this outcome parameter may be advantageous, we suggest to further investigate this outcome parameter on psychometric properties, such as test-retest reliability, correlation with bladder diary reported pad use, quantity of urine lost, and quality of life.
| Implication for research and clinical practice
Farag et al 37 reported on the success rates of surgical treatments for SUI in both adult and pediatric NU patients in a systematic review. Farag et al 37 compared the combined success rates of the included studies on urethral bulking agents to urethral sling procedures and artificial urinary sphincters. These studies however used variable definitions of success. A consistent comparison of the outcomes of therapy can only be made after standardization of outcome parameters and definitions of cure or success. We therefore recommend developing a core outcome set for use in UI research with NU patients. It is important that not only medical experts, but also patients and caregivers will be involved in the development of this outcome set, in order to include the various perspectives and also to increase the willingness to implement the outcome set. Until such a set has been developed, we recommend using an objective and a subjective outcome parameter and the combination of both to define cure. Because of the importance of the quality of life, specifically in NU patients, we recommend the use of a disease-specific quality of life questionnaire or a bother questionnaire validated for NU patients such as the (SF-)Qualiveen 33,34 as a subjective outcome parameter. Implementing such questionnaires in both research and clinical practice places a focus on optimization of the quality of life for these patients and makes it possible to compare outcomes of different studies. A clear recommendation for the use of a specific objective parameter is not feasible because there is insufficient scientific evidence on the psychometric properties of the different objective measures (bladder diaries, urodynamics, and pad tests), specifically regarding NU patients. 38 
| Strengths and limitations
Performing this systematic review, we followed the recommended Cochrane 6 and PRISMA guidelines. 5 Our study gives a clear overview of all used urinary parameters and definitions of success or cure to report on the outcome of surgical interventions for SUI in NU patients, and will hopefully begin the dialogue to a future consensus on this topic. Unfortunately, the included studies were primarily retrospective and of poor scientific quality. Furthermore, subgroup analyses were not possible due to the limited number of included studies.
| CONCLUSIONS
This is the first systematic review that has evaluated the various urinary parameters and definitions of cure to report on outcome after surgery for SUI in adult NU patients. We found a considerable heterogeneity in used outcome parameters and definitions of cure. As it is difficult to interpret and compare the outcomes of different therapies as investigators use different reporting systems of outcomes and definitions of cure, the results of this study will hopefully begin the dialogue to a future consensus on this topic.
